22Apr 2017


  • M.Phil (Pharmacology), Pharm-D, Punjab Healthcare Commission. Lahore.
  • MBBS, RHC, Narang Mandi.Shiekhupura.
  • Pharm-D, College of Pharmacy, Lahore Medical & Dental College. Lahore.
  • MBBS, M.Sc (Medical Administration), Punjab Healthcare Commission. Lahore
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Genetic polymorphism significantly affects the therapeutic outcomes of Isoniazid (INH).Various controlled clinical trials have been conducted in India, East Africa, Hong Kong, Singapore, Czechoslovakia, and Britain, which showed that the acetylation phenotype of tuberculosis patients treated with INH is significant, when twice-weekly regimens are given, especially in circumstances in which short initial daily chemotherapy is given. This article will review frequency of slow and fast acetylators in different populations of the world, before illustrating various methods used for the determination of INH and its metabolites used to determine the acetylation phenotype of the individuals. It will also highlight the importance of phenotypic determination on N-Acetyltransferase-2 (NAT-2) during tuberculosis treatment with INH.

  1. Calo, C. C., and V. Quercia. (1976). Gas chromatographic separation of some antitubercular drugs . Chromatogr., 37, 194-196.
  2. Hutchings, R. D. M., B. Spragg, and P. A. Routledge. (1983). J. Chromatogr., 277, 385.
  3. Noda, K. M., K. Sogabe, T. Goromaru and S. Iguchi. (1978). Metabolism and excretion of isoniazid in man: Quantitative determination of hydrazine derived from isoniazid. Abstracts?? of?? 37th?? international?? congress of pharmaceutical sciences in the Hague, 128.
  4. C. Li, H. J., W. Z. Shou, M.S. Bryant, X. Jiang, and W. Naidong. (2004). Rapid Commun.
  5. Mass Spectrom., 18, 2343.
  6. Abdul Sattar Sohrani, B. A., Khalid Hussain Janbaz and Abdul Subhan Ijaz. (1992). Acetylator phenotype determination of? healthy? and tuberculosis affected? population of Punjab. . Journal of Research (Science), Bahauddin Zakariya University, Multan-Pakistan., Vol. 4, No. 1., 53-57.
  7. Akhtar N., T. I. a. A. J. (2011). A genderwise study of Arylamine N-acetyltransferase 2 (NAT2) acetylation phenotyping using sulphamethazine by high pressure liquid chromatography (HPLC) assay. African Journal of Pharmacy and Pharmacology, 5:1739-1747.
  8. Al-Yahee, S. G., U. Al-Ameri, M. M. Qureshi, M. Zadjali, F. Ali, B.H. and Bayoumi R. (2007). N?acetyltransferase polymorphism among northern Sudanese.? . Human Biology, 79(4):? 455-452.
  9. , K. J. M. P. R. (1952). Amer. Rev. Tuberc., 65, 484.
  10. N. Ames, J. M., E. Yamasaki. (1975). Methods for detecting carcinogens and mutagens wth the Salmonella/ mamalina-microsome mutagenecity test. Mutation Res., 31, 347-363.
  11. Bell D. A., T. J. A., Butler M. A., Stephens E. A., Wiest J., Brubaker L. H.,, & Kadlubar F. F., a. L. (1993). G. W. Genotype/phenotype discordance for human arylamine N- acetyltransferase (NAT2) reveals a new slow-acetylator allele common
  12. in African-Americans. . Carcinogenesis (Lond.), 14: 1689-1692.
  13. Belles Q. C., L. M. L. (1960). Rev. Resp. Dis., 81, 364.
  14. Bernhard H. Lauterburg, C. V. S., Jerry R. Mitchell. (1981). Determination of hydrazine metabolites, acetyl INH, acetylhydrazine and diacetylhydrazine in human plasma using gas chromatography mass-spectrometery. Journal of Chromatography, 224, 431-438.
  15. Brans R., L. D., Khan A., Blomeke B. (2004). N-Acetyltransferase 2 Genotyping: An accurate and feasible approach for simultaneous detection of the most common NAT2 alleles. . Chem., 50: 1264-1266.
  16. Lacroix, G. L., J .P. Goulle, and J. Nouveau. (1984). J. Chromatogr., 307, 137. .
  17. Castaneda-Hernandez G., F.-N. A., Herrera-Abarca , Herrera J.E. and, & F.J., F.-M. (1995). Determination of three acetylator phenotypes in a Mexican population using sulfamethazine metabolic ratio.
  18. . J. Therapeutics, 2(1): 1-7.
  19. N. Rose, C. B. S. a. A. L. S. (1986). The age threshold for isoniazid chemoprophylaxis: a decision analysis for low-risk tuberculin reactors. J. Am. Med. Assoc., 256: 2709.
  20. DW, H. (2002). Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutation Research, 506-507: 65-77.
  21. , G.-M. (2008). Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Current Drug Metabolism, 9: 487-497.
  22. A. Ellard, P. T. G., and H. Tiitinen. (1973). Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: A study in Finnish Lappland. . Tubercle, 54:201-210.
  23. Miscoria, A. L., C. Walle and A. Roux. (1988). Ann. Biol. Clin., 46, 734.
  24. Gammon, G. A. E. a. P. T. (1976). Pharmacokinetics of isoniazid metabolism in man. Journal of Pharmacokinetics and Biopharmaceutics., Vol. 4, No.2.
  25. Georg Karlaganis, E. P. a. B. H. L. (1987). Analysis of isoniazid, acetylhydrazine and [15N2] acetylhydrazine in serum by capillary gas chromatography-ammonia chemical ionization mass spectrometry. Journal of Chromatography, 420: 171-177.
  26. Grob, K. G. a. G. (1983). Immobilization of vinylated OV‐17 and OV‐1701 based on combined surface bonding and crosslinking. High Resolut. Chromatogr. Chromatogr. Commun., 6: 153.
  27. Gross M., K., T., Anderson, K., Lang, N., McGovern, P., Delongchamp R. and Kadlubar F. (1999). Distribution and concordance of n-acetyltransferase genotype and phenotype in an American population. . Cancer Epidemiol. Biomarkers
  28. , 8: 683-692.
  29. Gupta R. C., N. C., Jindal S. K., Malik S. K. (1984). Incidence of INH acetylation phenotype in North Indians. . J. Clin. Pharmacol. Ther. Toxicol., 22: 259?264.
  30. I. Seifart, P. B. K., D. P. Parkin, P. P. Van Jaarsveld, and P. R. Donald. (1993). J. Chromatogr., 619, 285.
  31. I. Seifart, W. L. G., D. P. Parkin, P. P. Van Jaarsveld and P. R. Donald. (1995). J. Chromatogr., 674, 269.
  32. , P. J. (1960). Amer. Rev. Resp. Dis., 81, 485.
  33. Heller A., K. J. E., Clark L. & Roth L. J. (1961). Chem., 33, 1755.
  34. A. Blair, R. M. T., M. J. Boride, R. A. Clare, C. T. Dollery, J. A. Timbrell, I. A. Bever. (1985). Human Exp.
  35. , 4(195).
  36. , S. E. (1961). Tubercle. 42, 218.
  37. H. Peters, K. S. M., and P. Brown. (1965). Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. . J. Pharmacal. Exp.? Ther., 150:298-304.
  38. O. Svensson, A. M., and O. Ericsson. (1985). J. Chromatogr., 341, 193.
  39. Woo, C. L. W., R. Teoh, and K. Chan. (1987). J. Chromatogr., 420, 73.
  40. A. Timbrell, J. M. W. a. C. M. S. (1977). Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography. J. Chromatogr., 138: 165.
  41. Jack A. Taylor, D. M. U., Elizabeth Stephens, Trisha Castranio, David Paulson, Gary Robertson, James L. Mohler, and Douglas A. Bell. (1988). The role of w-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction. CANCER RESEARCH, 58, 3603-3610.
  42. Matsuyama, A. N., T. Goromaru, K. Sogabe, K. Y. Hsu, N. Otsuji,?? and S. Iguchi. (1977). Metabolism? and? excretion? of isoniazid in man:? Real state of hydrazine? and acetylhydrazine? in? human? urine. . Abstracts of 9th symposium on drug?? metabolism and action,?? Kumamoto, Japan., 49.
  43. , N. W. G. (1959a). Arzneim.-Forsch., 9, 636.
  44. Maher J. R., W. J. M., Chambers J. S. & Stononis D. J. (1957). Rev. Tuberc., 76, 852.
  45. Matar K. M., M. A. Y., Ayoola E. A., Bawazir S.A., Al-Fateh, F.Z. and Al-Wazzan A. (2004). Isoniazid acetylation phenotyping in Saudi Arab. . Clin. Pharm. and Therapeutics, 29: 443-47.
  46. Meyer U. A, Z. U. M. (1997). Molecular mechanisms of genetic polymorphisms of drug metabolism. . Rev. Pharmacol. Toxicol., 37: 269?96.
  47. Mitchison, W. F. a. D. A. (1975). Short course chemotherapy for pulmonary tuberculosis. Rev. Resp. Dis. Ill, 325-352.
  48. Mohammad Saleem, S. A. M., Maqsood Ahmed, Najeeba Saleem. (1989). Isoniazid acetylation and polymorphism in humans. . JPMA, 39: 285.
  49. Nielsch, W. G., L. (1959b). -Forsch., 9, 700.
  50. , E. L. C. a. O. (1978). Acetylation of sulphamethazine in a Nigerian population. . J. Biochemical Genetics, 16: 1073-1077.
  51. Pathak, C. D. G. a. P. V. (1990). Chromatogr., 97, 418.
  52. Mil?n-Segovia, G. P.-F., J. D. Torres-Tirado, X. Hermosillo-Ram?rez, M. Vigna-P?rez, and S. Romano-Moreno. (2007). Simultaneous HPLC Determination Of Isoniazid And Acetylisoniazid In Plasma. . ACTA Chromatographica, No.19.
  53. Rind, M. Y. K. a. F. M. A. (2002). Chromatogr., B, 766, 357.
  54. , H. (2009). Evaluation of the sulphadimidine acetylator phenotyping test in
  55. patients with reduced renal function. Acta Medica Scandinavica, 209(1-6): 505-507.
  56. Scott E. M. & Wright, R. C. (1967). lab. clin. Med., 70, 355.
  57. Van der Ven A. J., M. M. A., Vree T. B., Koopmans P. P. and Van der Meer J. W. (1994). Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. Br J Clin Pharmacol, 38(2): 147-150.
  58. Venkataraman P., E. L. T. S. P. (1968). Tubercle, 49, 210.
  59. Vree T. B., O. R. W. J., Hekster, Y. A., Damsma J. F. and Van der Kleijn E. (1980). Determination of the acetylator phenotype and pharmacokinetics or sulfonamides in man. . Pharmacokin., 5: 279-294.
  60. , F. (1968). Amer. Rev. Resp. Dis., 97, 767.
  61. Von Sassen, M. C.-P., E. Mush, and M. Eichelbaum. (1985). J. Chromatogr., 338, 113
  62. Chen, B. S., H. Jiang, K. Yu, and D. Zhong. (2005). Rapid Commun. Mass Spectrom. 19, 2591.
  63. Xie H. G., X. Z. H., Ou-Yang D. S., Shu Y., Yang D. L., Wang J. S., Yan X. D., Huang S. L., Wang W. and Zhou H. H. (1997). Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations. . Pharmacogenetics, 7(6): 503-14.
  64. Zaid R. B., N. M., Neelotpol S., Sayeed M. A., Banu A., Shurovi S., Hassan K. N., Salimullah M., Ali L. and Azad Khan A. K. (2007). Importance of acetylator phenotype in the identity of Asian populations. Human Biology, 79(3): 363-368.
  65. Zbinden, M. F.-S. a. G. (1975). A specific rapid gas chromatographic assay?? for the determination of isoniazid N-acetylation: Observation in rats with induced constant urine flow. Med., 14, 274-284.

[Sara Sattar, Zain-ul-Abadin, Muzamil Aftab and Anees Qureshi. (2017); ANALYTICAL TECHNIQUES TO IDENTIFY SLOW AND FAST ACETYLATORS OF NAT-2 ENZYME USING ISONIAZID. Int. J. of Adv. Res. 5 (4). 307-313] (ISSN 2320-5407). www.journalijar.com

Sara Sattar
Dr. Zain-ul-Abadin


Article DOI: 10.21474/IJAR01/3812       DOI URL: http://dx.doi.org/10.21474/IJAR01/3812

Share this article